GB9913341D0 - Treatment and prevention of type 1 IgE-mediated hypersensitivity - Google Patents

Treatment and prevention of type 1 IgE-mediated hypersensitivity

Info

Publication number
GB9913341D0
GB9913341D0 GBGB9913341.5A GB9913341A GB9913341D0 GB 9913341 D0 GB9913341 D0 GB 9913341D0 GB 9913341 A GB9913341 A GB 9913341A GB 9913341 D0 GB9913341 D0 GB 9913341D0
Authority
GB
United Kingdom
Prior art keywords
ige
prevention
treatment
type
mediated hypersensitivity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9913341.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NASSIEF NIDA A
Original Assignee
NASSIEF NIDA A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9904777.1A external-priority patent/GB9904777D0/en
Priority claimed from GBGB9908034.3A external-priority patent/GB9908034D0/en
Application filed by NASSIEF NIDA A filed Critical NASSIEF NIDA A
Publication of GB9913341D0 publication Critical patent/GB9913341D0/en
Priority to GB0005003A priority Critical patent/GB2348132B/en
Priority to EP00909548A priority patent/EP1242102B1/en
Priority to EP06114106A priority patent/EP1709995A1/en
Priority to PCT/IB2000/000222 priority patent/WO2000051580A2/en
Priority to ES00909548T priority patent/ES2267505T3/en
Priority to AU31829/00A priority patent/AU3182900A/en
Priority to DE60028243T priority patent/DE60028243T2/en
Priority to AT00909548T priority patent/ATE326979T1/en
Priority to HK03102127.9A priority patent/HK1049964A1/en
Ceased legal-status Critical Current

Links

GBGB9913341.5A 1999-03-02 1999-06-08 Treatment and prevention of type 1 IgE-mediated hypersensitivity Ceased GB9913341D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GB0005003A GB2348132B (en) 1999-03-02 2000-03-01 Asthma/allergy therapy that targets t-lymphocytes and/or eosinophils
AT00909548T ATE326979T1 (en) 1999-03-02 2000-03-02 ASTHMA AND ALLERGY TREATMENT TARGETED ON T-LYMPHOCYTES AND/OR EOSINOPHILS
DE60028243T DE60028243T2 (en) 1999-03-02 2000-03-02 ASTHMA AND ALLERGY TREATMENT FACILITATED TO T-LYMPHOCYTES AND / OR EOSINOPHILES
AU31829/00A AU3182900A (en) 1999-03-02 2000-03-02 Asthma/allergy therapy that targets t-lymphocytes and/or eosinophils
EP06114106A EP1709995A1 (en) 1999-03-02 2000-03-02 Asthma/allergy therapy using nigella sativa
EP00909548A EP1242102B1 (en) 1999-03-02 2000-03-02 Asthma/allergy therapy that targets t-lymphocytes and/or eosinophils
PCT/IB2000/000222 WO2000051580A2 (en) 1999-03-02 2000-03-02 Asthma/allergy therapy that targets t-lymphocytes and/or eosinophils
ES00909548T ES2267505T3 (en) 1999-03-02 2000-03-02 TREATMENT OF ASTHMA / ALLERGY TAKING OBJECTIVES THE LYMPHOCYTES T AND / OR EOSINOFILOS.
HK03102127.9A HK1049964A1 (en) 1999-03-02 2003-03-24 Asthma/allergy therapy that targets t-lymphocytes and/or eosinophils

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9904777.1A GB9904777D0 (en) 1999-03-02 1999-03-02 Novel method, an asthma therapy that act on eosinophils and/or t-lymphocytes
GBGB9908034.3A GB9908034D0 (en) 1999-04-08 1999-04-08 Treatment and prevention of type 1 IgE-mediated hypersensitivity

Publications (1)

Publication Number Publication Date
GB9913341D0 true GB9913341D0 (en) 1999-08-11

Family

ID=26315205

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9913341.5A Ceased GB9913341D0 (en) 1999-03-02 1999-06-08 Treatment and prevention of type 1 IgE-mediated hypersensitivity

Country Status (1)

Country Link
GB (1) GB9913341D0 (en)

Similar Documents

Publication Publication Date Title
HK1094535A1 (en) Prevention and treatment of amyloidogenic disease
GB2368794B (en) Prevention and treatment of amyloidogenic disease
IL132003A0 (en) Antimicrobial prevention and treatment of human immundeficiency virus and other infectious diseases
HUP0201205A3 (en) Prevention and treatment of amyloidogenic disease
IL127664A (en) Compositions for the treatment and prevention of cachexia
EP0999876A4 (en) Stereotactic radiotreatment and prevention of restenosis
HK1019205A1 (en) Galenic preparation for prevention and treatment of hepatocarcinoma.
HK1043019B (en) Compositions and methods for prevention and treatment of protozoal disease
AU2300001A (en) Pharmaceutical compositions useful in the prevention and treatment of beta-amyloid protein-induced disease
IL138692A0 (en) Treatment and prevention of vascular disease
IL141211A0 (en) Prevention and treatment of viral disease
AU2964199A (en) Prevention and treatment of adhesions
GB9908034D0 (en) Treatment and prevention of type 1 IgE-mediated hypersensitivity
GB9913341D0 (en) Treatment and prevention of type 1 IgE-mediated hypersensitivity
EP1173189A4 (en) Asialocytokines and treatment of liver disease
EP0833641A4 (en) Treatment and prevention of prostatic disease
GB9516572D0 (en) Prevention and/or treatment of disease
AU1392601A (en) Prevention and treatment of biomaterial-associated infections
EP0929540A4 (en) Antitumor compositions and methods of treatment
AU4556899A (en) Prevention and treatment of sepsis
GB9810218D0 (en) Treatment of the symptons of aggression behavioural disinhibition and behavioural disturbance
GB9709293D0 (en) MEK inhibiting compositions and methods of treatment
GB9918538D0 (en) Improved treatment of dentine hypersensitivity
GB0030866D0 (en) Treatment and prevention of disease
GB0030865D0 (en) Treatment and prevention of disease

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)